SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

Multiple Assemblies exist for SMTL entry 5qch
Crystal structure of human Cathepsin-S with bound ligand; X-RAY DIFFRACTION 2.20 Å

SMTL ID
5qch.1
Ligands
SULFATE ION; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide
Polypeptides
Cathepsin S
Oligo-state
monomer
SMTL ID
5qch.2
Ligands
SULFATE ION; GLYCEROL; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide
Polypeptides
Cathepsin S
Oligo-state
monomer
SMTL ID
5qch.3
Ligands
SULFATE ION; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide
Polypeptides
Cathepsin S
Oligo-state
monomer
SMTL ID
5qch.4
Ligands
SULFATE ION; GLYCEROL; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide
Polypeptides
Cathepsin S
Oligo-state
monomer